Free Trial
LON:TCF

Theracryf 6/3/2025 Earnings Report

GBX 0.24 -0.01 (-3.60%)
As of 04:12 AM Eastern

Theracryf EPS Results

Actual EPS
-GBX 0.36
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Theracryf Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Theracryf Announcement Details

Quarter
Time
Before Market Opens
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

Theracryf Earnings Headlines

TheraCryf appoints new board member, issues options
Theracryf Plc (TCF.L)
New Buy Alert: Should you put $1,000 into Oracle (ORCL) now?
Barron's is calling this Oracle's "Nvidia Moment..." While the Wall Street Journal is simply calling Oracle the "New Nvidia." But is Oracle really the #1 AI stock you should buy today?tc pixel
Theracryf PLC Share Chat (TCF)
See More Theracryf Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Theracryf? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Theracryf and other key companies, straight to your email.

About Theracryf

Theracryf (LON:TCF) is a clinical stage therapeutics company developing a new generation of innovative therapeutics in behavioural brain disorders. TheraCryf’s strategy is to generate compelling data sets with a goal of partnering its programmes with mid-size to large pharma. Behavioural brain disorders such as opioid and alcohol abuse, binge eating disorder, anxiety and fatigue affect more than 50 million people worldwide. TheraCryf’s mission is to develop and partner novel medicines to significantly improve the lives of people with these debilitating conditions and help them enjoy life.

View Theracryf Profile

More Earnings Resources from MarketBeat